Precipio Diagnostics Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Precipio Diagnostics's estimated annual revenue is currently $24M per year.(i)
  • Precipio Diagnostics's estimated revenue per employee is $270,000

Employee Data

  • Precipio Diagnostics has 89 Employees.(i)
  • Precipio Diagnostics grew their employee count by 6% last year.

Precipio Diagnostics's People

NameTitleEmail/Phone
1
Co-Founder & COOReveal Email/Phone
2
Co-Founder & COOReveal Email/Phone
3
CEOReveal Email/Phone
4
CFOReveal Email/Phone
5
VP, Administrative OperationsReveal Email/Phone
6
VP Pathology SalesReveal Email/Phone
7
SVP, Products DivisionReveal Email/Phone
8
Snr. Director Learning and Development, Customer ExperienceReveal Email/Phone
9
Director MarketingReveal Email/Phone
10
Chief Technology OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$22.7M84-26%N/AN/A
#2
$9.3M438%N/AN/A
#3
$18.2M751%N/AN/A
#4
$16.3M6749%N/AN/A
#5
$42.8M1447%N/AN/A
#6
$17.5M729%N/AN/A
#7
$27.5M10211%N/AN/A
#8
$8.9M4111%N/AN/A
#9
$27.8M1034%N/AN/A
#10
$9.7M452%N/AN/A
Add Company

What Is Precipio Diagnostics?

Precipio is a cancer diagnostics reference laboratory, delivering the latest in advanced diagnostics and personalized medicine. Our goal is to assist oncologists in providing the best care for their patients. At the intersection of academia, cancer research, and diagnostics, we connect physicians with world-renown pathologists at the Yale School of Medicine. At Precipio, our customers and their patients benefit from the most accurate, expert diagnosis. We provide our customers exclusive access to some of the most innovative tests in the field of molecular diagnostics, developed through cutting edge research, and the ongoing pursuit and refinement of the science of personalized medicine.

keywords:N/A

N/A

Total Funding

89

Number of Employees

$24M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Precipio Diagnostics News

2022-04-19 - Precipio customer American Oncology Network (AON ...

NEW HAVEN, Conn., April 26, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), is excited to...

2022-04-19 - Precipio customer American Oncology Network (AON) selected to present HemeScreen® technology case study at Industry leading clinical laboratory conference

(NASDAQ: PRPO), is excited to announce its participation and the presentation of HemeScreen, its novel diagnostic technology platform, at the...

2022-04-17 - Is Precipio Inc (PRPO) a Winner in the Diagnostics & Research Industry?

Is Precipio Inc (PRPO) a Winner in the Diagnostics & Research Industry? Monday, April 25, 2022 10:04 AM | InvestorsObserver Analysts. Is Precipio Inc (PRPO)...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M896%N/A
#2
$18.7M896%N/A
#3
$31.8M907%N/A
#4
$16.2M9076%N/A
#5
N/A9114%N/A